Gustavo A. Ordonez, MD

Univeridad Del Valle
Cali, Valle del Cauca, Colombia

Disclosure(s): Megalabs, Tecnoquimicas SA and MSD: Grant/Research Support, Honoraria, Principal Investigator for the study for MSD

Presentation(s):

• 167 - Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease

  Thursday, October 17, 2024
  2:21 PM – 2:33 PM US PT